Intimation of Appointment of CFO Pursuant to Regulation 30 of SEBI(LODR) Regulation 2015.

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.7%Reaction day

₹0.85

prior close

₹0.85

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.3%+3.4% vs market

Pharmaceuticals peers, median of 146sector+0.5%+4.2% vs sector

On the reaction day the stock moved 3.4 pts more than Nifty Microcap 250 and 4.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+4.7

30m

+4.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.7+1.3+3.4+0.5+4.2

Next day

+9.4+0.4+9.0-0.5+9.9

+15.3+0.3+15.0-0.8+16.1

+18.8+5.0+13.9+2.3+16.5

+20.0+6.7+13.3+2.9+17.1

+22.4+8.4+14.0+3.8+18.6

+25.9+10.3+15.6+4.8+21.0

15d

+27.1+12.8+14.2+7.3+19.8

+22.4+16.0+6.3+5.9+16.4

+24.7+16.9+7.8+8.3+16.4

+12.9+12.5+0.4+5.3+7.7

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 146Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Welcure Drugs & Pharmaceuticals has appointed Mr. Chintan Didawala Ganpat as its new Chief Financial Officer, effective May 6, 2025. The appointment was made by the Board based on the recommendation of the Nomination & Remuneration Committee. The change was needed to fill a casual vacancy created by the resignation of the previous CFO. Mr. Chintan brings experience in finance and management and currently holds no shares in the company.

Likely market impact

While appointing a new CFO is a routine governance update, the underlying signal is that the previous CFO resigned mid-term, which shareholders may want to monitor for any deeper reasons behind the departure.